Archives
-
Mouse Neutrophil Cell Isolation in Immunotherapy
2026-08-25
Neutrophils are moving from experimental bystanders to programmable effectors in cancer immunotherapy. This thought-leadership article explains why activation-conscious mouse neutrophil isolation is strategically important for validating neutrophil-targeted nanovaccines and translating mechanistic findings into reproducible assays.
-
4Q Design for Stable Polymeric mRNA Delivery
2026-08-24
Shi and colleagues introduced a “4Q” framework that separates mRNA delivery into vector stability, diffusion, cellular entry, and intracellular release. Their polycatechol PBD system addressed the trade-off between room-temperature storage and cytoplasmic release, producing stable polyplexes and substantially stronger in vivo transfection than a jetPEI/mRNA comparator.
-
Ibrexafungerp: Translational Leverage Against Candida
2026-08-24
Ibrexafungerp, also known as MK 3118, illustrates how a differentiated glucan synthase mechanism can create translational value beyond conventional susceptibility results. This article connects resistance biology, acidic-pH activity, standardized assay design, delayed-treatment animal models, and clinical strategy to help researchers evaluate the compound with greater rigor and clearer development priorities.
-
IGF2BP1–THBS1–TLR4 Axis in Pulmonary Fibrosis
2026-08-23
The 2025 reference study identifies an m6A-dependent IGF2BP1–THBS1–TLR4 pathway that links macrophage RNA regulation to glycolytic reprogramming and fibrotic polarization in pulmonary fibrosis. Its knockdown, rescue, tissue, and metabolic experiments provide a mechanistic framework for interpreting macrophage contributions to fibrosis while highlighting important limits of the bleomycin model.
-
Blebbistatin in Structure–Function Assays
2026-08-22
(±)-Blebbistatin is a reversible non-muscle myosin II inhibitor for dissecting force-dependent changes in cell behavior. This guide connects its mechanism and handling with multimodal structure–function imaging, emphasizing assay interpretation, controls, and cross-domain limitations.
-
Peptidisc-Assisted Nanobody Multimerization
2026-08-22
The reference preprint introduces peptidisc-assisted hydrophobic clustering as a way to assemble nanobodies into soluble multimeric, bispecific, and autofluorescent proteins. Its results indicate that membrane-mimetic stabilization can preserve hydrophobically driven assemblies while improving avidity and expanding nanobody engineering options beyond tandem fusion or scaffold-based designs.
-
Cisplatin (CDDP): Workflows for Resistance Studies
2026-08-21
Turn Cisplatin (CDDP) into a controlled benchmark for DNA damage, apoptosis, ferroptosis, and chemotherapy resistance studies. This practical guide connects cell viability assays with mechanistic validation and carefully framed xenograft applications.
-
Linoleic Acid C18:2: Practical Lab Guide
2026-08-20
Linoleic Acid (SKU C3108) provides a defined C18:2(9Z,12Z) input for studying membrane behavior, oxidative stress, epithelial migration, erythrocyte injury, and essential fatty acid biology. It is water-insoluble and should be handled as a freshly prepared ethanol- or DMSO-based solution rather than a long-term aqueous stock.
-
Sulfo-NHS-SS-Biotin for Notch Surface Proteomics
2026-08-20
Sulfo-NHS-SS-Biotin enables reversible labeling of cell-surface proteins, making it useful for tracking receptor internalization, recycling, and affinity enrichment. Paired with spatial proteomics methods such as TurboID, it can distinguish surface-accessible Notch pools from broader compartment-specific interaction networks.
-
HyperScribe T7 High Yield RNA Synthesis Kit Plus
2026-08-19
Explore how the HyperScribe T7 High Yield RNA Synthesis Kit Plus can support controlled FLCN mRNA rescue assays in Birt-Hogg-Dubé research. This article focuses on assay architecture, transcript quality, controls, and interpretation rather than repeating a general therapeutic workflow.
-
Sulfo-NHS-SS-Biotin for Charge-Aware Surface Assays
2026-08-19
Sulfo-NHS-SS-Biotin enables reversible amine labeling for affinity capture while opening a charge-aware framework for cell-surface receptor assays. This guide connects cleavable biotin chemistry with CAR-T assay design, highlighting controls that distinguish true biology from labeling-induced clustering.
-
DAMGO: From MOR Assays to Pain-Circuit Logic
2026-08-18
DAMGO is a selective µ-opioid receptor agonist for connecting receptor activation with circuit-level pain biology. This guide shows how to interpret its biochemical, tissue, and mouse-model data without confusing assay potency with analgesic mechanism.
-
Gap19: Cx43 Hemichannel Selectivity in Stroke
2026-08-18
Gap19 is a selective connexin 43 hemichannel blocker for separating Cx43 channel functions from downstream inflammatory signaling. This article translates evidence from astrocyte, ischemia, and macrophage assays into a practical framework for rigorous mechanism-focused study design.
-
MK-571 (L-660,711) in Inflammation Assays
2026-08-17
MK-571 (L-660,711) enables researchers to separate cysteinyl leukotriene signaling from transporter-driven effects in airway, barrier, and macrophage models. Its dual value as a cysLT1 antagonist and MRP1/ABCC1 probe makes it especially useful for mechanism-focused inflammation and drug-response workflows.
-
Ibrexafungerp Activity at Acidic Vaginal pH
2026-08-17
The reference study showed that ibrexafungerp, also known as MK 3118, retained in vitro activity against diverse Candida isolates when susceptibility testing was performed at pH 4.5, a condition relevant to vulvovaginal candidiasis. Its design provides a useful framework for evaluating antifungal performance under clinically meaningful acidic conditions, particularly against fluconazole-resistant isolates.